Nautilus Biotechnology (NAUT)
(Delayed Data from NSDQ)
$2.53 USD
+0.12 (4.98%)
Updated Jun 20, 2024 04:00 PM ET
After-Market: $2.53 0.00 (0.00%) 6:04 PM ET
2-Buy of 5 2
D Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
NAUT 2.53 +0.12(4.98%)
Will NAUT be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for NAUT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NAUT
Nautilus Biotechnology (NAUT) Upgraded to Buy: Here's What You Should Know
NAUT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for NAUT
Nautilus Biotechnology assumed with a Hold from Buy at Jefferies
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Nautilus Biotechnology’s ESG Challenge: Navigating the Rising Tide of Corporate Responsibility Standards
Nautilus Biotechnology Inc (NAUT) Q1 2024 Earnings Call Transcript Highlights: A Detailed ...
Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings Call Transcript